Riemersma Moniek, Hazebroek Mark R, Helderman-van den Enden Appolonia T J M, Salomons Gajja S, Ferdinandusse Sacha, Brouwers Martijn C G J, van der Ploeg Liesbeth, Heymans Stephane, Glatz Jan F C, van den Wijngaard Arthur, Krapels Ingrid P C, Bierau Jörgen, Brunner Han G
Department of Clinical Genetics, Maastricht University Medical Center+, Maastricht, The Netherlands.
School for Cardiovascular Diseases, Maastricht University Medical Center+, Maastricht, The Netherlands.
Eur J Hum Genet. 2017 Nov;25(11):1195-1201. doi: 10.1038/ejhg.2017.127. Epub 2017 Aug 30.
Dilated cardiomyopathy (DCM) is extremely heterogeneous with a large proportion due to dominantly inherited disease-causing variants in sarcomeric genes. Recessive metabolic diseases may cause DCM, usually with onset in childhood, and in the context of systemic disease. Whether metabolic defects can also cause adult-onset DCM is currently unknown. Therefore, we performed an extensive metabolic screening in 36 consecutive adult-onset DCM patients. Diagnoses were confirmed by Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Measurement of propionyl-CoA carboxylase (PCC) activity was done in fibroblasts. Whole exome sequencing (WES) data of 157 additional DCM patients were analyzed for genetic defects. We found a metabolic profile characteristic for propionic acidemia in a patient with severe DCM from 55 years of age. Genetic analysis demonstrated compound heterozygous variants in PCCA. Enzymatic activity of PCC in fibroblasts was markedly reduced. A targeted analysis of the PCCA and PCCB genes using available WES data from 157 further DCM patients subsequently identified another patient with propionic acidemia. This patient had compound heterozygous variants in PCCB, and developed severe DCM from 42 years of age. Adult-onset DCM can be caused by propionic acidemia, an autosomal recessive inheritable metabolic disorder usually presenting as neonatal or childhood disease. Current guidelines advise a low-protein diet to ameliorate or prevent detrimental aspects of the disease. Long-term follow-up of a larger group of patients may show whether this diet would also ameliorate DCM. Our results suggest that diagnostic metabolic screening to identify propionic acidemia and related disorders in DCM patients is justified.
扩张型心肌病(DCM)具有高度异质性,其中很大一部分是由于肌节基因中显性遗传的致病变异所致。隐性代谢疾病可能导致DCM,通常在儿童期发病,且常伴有全身性疾病。目前尚不清楚代谢缺陷是否也会导致成人期DCM。因此,我们对36例连续的成人期DCM患者进行了广泛的代谢筛查。诊断通过桑格测序和多重连接依赖探针扩增(MLPA)得以证实。在成纤维细胞中测定了丙酰辅酶A羧化酶(PCC)的活性。对另外157例DCM患者的全外显子测序(WES)数据进行了遗传缺陷分析。我们在一名55岁患有严重DCM的患者中发现了丙酸血症的特征性代谢谱。基因分析显示PCCA存在复合杂合变异。成纤维细胞中PCC的酶活性显著降低。随后,利用157例其他DCM患者的现有WES数据对PCCA和PCCB基因进行靶向分析,又发现了一名丙酸血症患者。该患者PCCB存在复合杂合变异,42岁时出现严重DCM。成人期DCM可由丙酸血症引起,这是一种常染色体隐性遗传性代谢紊乱疾病,通常表现为新生儿或儿童疾病。目前的指南建议采用低蛋白饮食来改善或预防该疾病的有害影响。对更多患者进行长期随访可能会显示这种饮食是否也能改善DCM。我们的结果表明,对DCM患者进行诊断性代谢筛查以识别丙酸血症及相关疾病是合理的。